AGC Biologics expands cell therapy development operations to Asia

AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC...

June 26, 2025 | Thursday | News
Japan's Fujirebio acquires Plasma Services Group to provide biological raw materials to IVD industries

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. has announced that Fujirebio Diagnos...

June 24, 2025 | Tuesday | News
Ono Pharma and Vertex to commercialise Povetacicept in Japan and South Korea for nephropathy treatment

Japan-based Ono Pharmaceutical Co., and Vertex Pharmaceuticals Incorporated, in the US, have announced an exclusive coll...

June 24, 2025 | Tuesday | News
Harbour BioMed & Otsuka Pharma ink $670 M agreement for treatment of autoimmune diseases

Harbour BioMed, a China-based biopharmaceutical company, has announced a global strategic collaboration with Japan-headq...

June 23, 2025 | Monday | News
Japan gives nod to Israeli startup MedHub-AI's coronary physiology diagnostic software

Israel-based startup MedHub-AI, a global leader in artificial intelligence (AI)-powered cardiovascular diagnostics,...

June 20, 2025 | Friday | News
NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment in Japan

Japan-based NEC Corporation, in collaboration with Chugai Pharmaceutical Co., has conducted an experiment usin...

June 19, 2025 | Thursday | News
Avata Biosciences partners with Oceanus Bio for developing oral cannabidiol therapies to address Epilepsy and Schizophrenia

UK-based Avata Biosciences Holdings has signed a co-development and licensing agreement with Oceanus Bio, Inc. for the e...

June 18, 2025 | Wednesday | News
HekaBio teams up with Alfresa Holdings Corp accelerating access to innovative therapies in Japan

HekaBio K.K. has announced the signing of a strategic partnership agreement with Alfresa Holdings Corporation, a leading...

June 17, 2025 | Tuesday | News
SDP Japan raises $31 M to rollout advanced surgical care models

Healthcare startup SDP Japan, Inc. has raised approximately JPY 4.5 billion (equivalent to $31 million) t...

June 16, 2025 | Monday | News
Mitsubishi Research Institute and Astellas collaborate to support pharma startups in Japan

Mitsubishi Research Institute, Inc.  and Astellas Pharma Inc. have agreed on a Memorandum of Understanding (MoU) to...

June 13, 2025 | Friday | News
Olympus announces full market release of AI-powered emphysema screening programme

Japan headquartered medtech firm Olympus Corp. has announced the full market release of its artificial intelligence (AI)...

June 12, 2025 | Thursday | News
Cardio Diagnostics secures Japanese patent for AI-driven cardiovascular disease detection technology

Cardio Diagnostics Holdings Inc., a US-based artificial intelligence (AI)-powered precision cardiovascular medicine comp...

June 10, 2025 | Tuesday | News
Samsung Bioepis enters into strategic partnership with Nipro for commercialisation of multiple biosimilars in Japan

South Korea-based Samsung Bioepis Co. has entered into a license, development and commercialisation agreement with Nipro...

June 9, 2025 | Monday | News
Japan transforms engineered heart tissues for precise drug testing

A research team led by Associate Professor Yoshinori Yoshida and Specially Appointed Assistant Professor Yuya ...

June 7, 2025 | Saturday | News
Telix Pharma establishes new operations in Japan

Australia-headquartered Telix Pharmaceuticals has established Telix Manufacturing Solutions (TMS) in Yokohama, Japan. Te...

June 5, 2025 | Thursday | News
Japanese startup ThinkCyte unveils cloud-based platform for AI-driven cell morphology data analysis

ThinkCyte, a Japan-based life science company pioneering advanced artificial intelligence (AI)-powered cell analysis and...

June 4, 2025 | Wednesday | News
Japan's Fujifilm rebrands Life Sciences companies to represent board spectrum portfolio

Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering products, s...

June 3, 2025 | Tuesday | News
Eisai launches Pariet® S, first proton pump inhibitor RX-to-OTC in Japan

Eisai Co. has announced the launch of Pariet® S”(pharmaceutical requiring guidance), which is highly effective...

June 2, 2025 | Monday | News
Japan establishes first next-gen commercial production site for CAR-T cell therapies

Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, has announced the est...

May 30, 2025 | Friday | News
Japan's Olympus announces US FDA clearance of its most advanced imaging endoscopes

Olympus, a Japan-headquartered medical technology company, has announced the US FDA 510(k) clearance of its EZ1500 serie...

May 28, 2025 | Wednesday | News
Fujitsu, THERS utilise AI to accelerate clinical research and tackle 'drug loss' in Japan

Fujitsu Limited and Tokai National Higher Education and Research System (THERS) have announced the successful completion...

May 26, 2025 | Monday | News
Alloy Therapeutics enters Japanese market by establishing operations at Shonan Health Innovation Park

Alloy Therapeutics Inc., a US-based biotechnology ecosystem company, has recently opened its first location in Japa...

May 23, 2025 | Friday | News
Japan's Ubitus collaborates with MacKay Memorial Hospital in Taiwan for AI-powered multi-modal medical robots

Japan-based Ubitus, a global leader in cloud streaming and artificial intelligence (AI) solutions, has announced its col...

May 22, 2025 | Thursday | News
Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced th...

May 21, 2025 | Wednesday | News
Japanese startup RevolKa secures $1.4 M funding to advance therapeutic programmes

RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven protein engi...

May 20, 2025 | Tuesday | News